Devil's claw: action on the central nervous system
暂无分享,去创建一个
L. F. Krause | M. F. Ribeiro | Cristiane Köhler Carpilovsky | Valtieri Bortoluzzi de Lima | Paula KöHLER Carpilovsky
[1] K. Prasad,et al. Devil's claw (Harpagophytum procumbens) ameliorates the neurobehavioral changes and neurotoxicity in female rats exposed to arsenic , 2020, Heliyon.
[2] Jiankun Cui,et al. Harpagophytum procumbens Extract Ameliorates Allodynia and Modulates Oxidative and Antioxidant Stress Pathways in a Rat Model of Spinal Cord Injury , 2020, NeuroMolecular Medicine.
[3] G. Orlando,et al. Devil's claw (Harpagophytum procumbens) and chronic inflammatory diseases: A concise overview on preclinical and clinical data , 2019, Phytotherapy research : PTR.
[4] Haifeng Zhang,et al. Harpagoside Rescues the Memory Impairments in Chronic Cerebral Hypoperfusion Rats by Inhibiting PTEN Activity. , 2018, Journal of Alzheimer's disease : JAD.
[5] M. Vacca,et al. Protective Effects Induced by Microwave‐Assisted Aqueous Harpagophytum Extract on Rat Cortex Synaptosomes Challenged with Amyloid β‐Peptide , 2017, Phytotherapy research : PTR.
[6] A. Boligon,et al. Harpagophytum Procumbens Ethyl Acetate Fraction Reduces Fluphenazine-Induced Vacuous Chewing Movements and Oxidative Stress in Rat Brain , 2016, Neurochemical Research.
[7] X. Sun,et al. Harpagoside ameliorates the amyloid-β-induced cognitive impairment in rats via up-regulating BDNF expression and MAPK/PI3K pathways , 2015, Neuroscience.
[8] Jeong Ah Kim,et al. Cholinesterase inhibitors from the roots of Harpagophytum procumbens , 2014, Archives of pharmacal research.
[9] A. Boligon,et al. Harpagophytum procumbens Prevents Oxidative Stress and Loss of Cell Viability In Vitro , 2013, Neurochemical Research.
[10] Milen I Georgiev,et al. Harpagoside: from Kalahari Desert to pharmacy shelf. , 2013, Phytochemistry.
[11] K. Nakazawa,et al. GABAergic interneuron origin of schizophrenia pathophysiology , 2012, Neuropharmacology.
[12] Milen I Georgiev,et al. Cholinesterases Inhibitory and Antioxidant Activities of Harpagophytum procumbens from In Vitro Systems , 2012, Phytotherapy research : PTR.
[13] S. D. de Mello,et al. Effect of isolated fractions of Harpagophytum procumbens D.C. (devil's claw) on COX‐1, COX‐2 activity and nitric oxide production on whole‐blood assay , 2010, Phytotherapy research : PTR.
[14] A. Warnock,et al. A review of the biological and potential therapeutic actions of Harpagophytum procumbens , 2007, Phytotherapy research : PTR.
[15] J. Ojewole,et al. Anticonvulsant activity of Harpagophytum procumbens DC [Pedaliaceae] secondary root aqueous extract in mice , 2006, Brain Research Bulletin.
[16] D. Cole,et al. The commercial harvest of devil's claw (Harpagophytum spp.) in southern Africa: the devil's in the details. , 2005, Journal of ethnopharmacology.
[17] I. Mahomed,et al. Analgesic, antiinflammatory and antidiabetic properties of Harpagophytum procumbens DC (Pedaliaceae) secondary root aqueous extract , 2004, Phytotherapy research : PTR.
[18] J. Pfeilschifter,et al. Downregulation of iNOS expression in rat mesangial cells by special extracts of Harpagophytum procumbens derives from harpagoside-dependent and independent effects. , 2004, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[19] B.-E. Van Wyk,et al. People's Plants: A Guide to Useful Plants of Southern Africa , 2000 .
[20] O. Eichler,et al. [Antiphlogistic, analgesic and spasmolytic effect of harpagoside, a glycoside from the root of Harpagophytum procumbens DC]. , 1970, Arzneimittel-Forschung.